15 related articles for article (PubMed ID: 26881525)
1. Effect of Doxorubicin on the Near-Infrared Optical Properties of Indocyanine Green.
Jaiswal S; Dutta SB; Nayak D; Gupta S
ACS Omega; 2021 Dec; 6(50):34842-34849. PubMed ID: 34963967
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells.
Skvortsova I; Popper BA; Skvortsov S; Saurer M; Auer T; Moser R; Kamleitner H; Zwierzina H; Lukas P
J Radiat Res; 2005 Jun; 46(2):241-8. PubMed ID: 15988143
[TBL] [Abstract][Full Text] [Related]
3. Rituximab increases the cytotoxicities of vincristine and hydroxyurea through caspase-dependent and caspase-independent cell death, respectively.
Tabal S; Elbanani A; Deyab M; Abulayha A
Cancer Biother Radiopharm; 2015 Apr; 30(3):125-31. PubMed ID: 25714921
[TBL] [Abstract][Full Text] [Related]
4. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
Liu C; DeNardo G; Tobin E; DeNardo S
Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447
[TBL] [Abstract][Full Text] [Related]
5. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
6. Camptothecin enhances
Kumar C; Sharma R; Repaka KM; Pareri AU; Dash A
J Cancer Res Ther; 2021; 17(4):943-950. PubMed ID: 34528546
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin enhances (131)I-rituximab induced cell death in Raji cells.
Kumar C; Pandey BN; Samuel G; Venkatesh M
J Cancer Res Ther; 2015; 11(4):823-9. PubMed ID: 26881525
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
